No abstract available
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adrenergic alpha-Antagonists / metabolism
-
Adrenergic alpha-Antagonists / pharmacokinetics
-
Adrenergic beta-Antagonists / metabolism
-
Adrenergic beta-Antagonists / pharmacokinetics
-
Adrenergic beta-Antagonists / therapeutic use*
-
Alleles
-
Atenolol / metabolism
-
Benzopyrans / metabolism
-
Biotransformation
-
Bisoprolol / metabolism
-
Carbazoles / blood
-
Carbazoles / metabolism
-
Carbazoles / pharmacokinetics
-
Carvedilol
-
Clinical Trials as Topic
-
Cytochrome P-450 CYP2D6 / genetics*
-
Ethanolamines / metabolism
-
Female
-
Genotype
-
Humans
-
Male
-
Metoprolol / administration & dosage
-
Metoprolol / blood
-
Metoprolol / metabolism
-
Metoprolol / therapeutic use
-
Mutation
-
Nebivolol
-
Pharmacogenetics*
-
Phenotype
-
Polymorphism, Genetic*
-
Propanolamines / blood
-
Propanolamines / metabolism
-
Propanolamines / pharmacokinetics
-
Risk Factors
-
Time Factors
Substances
-
Adrenergic alpha-Antagonists
-
Adrenergic beta-Antagonists
-
Benzopyrans
-
Carbazoles
-
Ethanolamines
-
Propanolamines
-
Nebivolol
-
Carvedilol
-
Atenolol
-
Cytochrome P-450 CYP2D6
-
Metoprolol
-
Bisoprolol